The present and future of deep learning in radiology.

Journal: European journal of radiology
Published Date:

Abstract

The advent of Deep Learning (DL) is poised to dramatically change the delivery of healthcare in the near future. Not only has DL profoundly affected the healthcare industry it has also influenced global businesses. Within a span of very few years, advances such as self-driving cars, robots performing jobs that are hazardous to human, and chat bots talking with human operators have proved that DL has already made large impact on our lives. The open source nature of DL and decreasing prices of computer hardware will further propel such changes. In healthcare, the potential is immense due to the need to automate the processes and evolve error free paradigms. The sheer quantum of DL publications in healthcare has surpassed other domains growing at a very fast pace, particular in radiology. It is therefore imperative for the radiologists to learn about DL and how it differs from other approaches of Artificial Intelligence (AI). The next generation of radiology will see a significant role of DL and will likely serve as the base for augmented radiology (AR). Better clinical judgement by AR will help in improving the quality of life and help in life saving decisions, while lowering healthcare costs. A comprehensive review of DL as well as its implications upon the healthcare is presented in this review. We had analysed 150 articles of DL in healthcare domain from PubMed, Google Scholar, and IEEE EXPLORE focused in medical imagery only. We have further examined the ethic, moral and legal issues surrounding the use of DL in medical imaging.

Authors

  • Luca Saba
    Department of Radiology, A.O.U., Italy.
  • Mainak Biswas
    Department of Computer Science and Engineering, NIT, Goa, India.
  • Venkatanareshbabu Kuppili
    Department of Computer Science and Engineering, NIT, Goa, India.
  • Elisa Cuadrado Godia
    IMIM - Hospital del Mar, Passeig Marítim 25-29, Barcelona, Spain.
  • Harman S Suri
    Brown University, Providence, RI, USA; Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA, USA.
  • Damodar Reddy Edla
    Department of Computer Science and Engineering, NIT, Goa, India.
  • Tomaž Omerzu
    Department of Neurology, University Medical Centre Maribor, Slovenia.
  • John R Laird
    UC Davis Vascular Center, University of California, Davis, CA, USA.
  • Narendra N Khanna
    Cardiology Department, Apollo Hospitals, New Delhi, India.
  • Sophie Mavrogeni
    Cardiology Clinic, Onassis Cardiac Surgery Center, Athens, Greece.
  • Athanasios Protogerou
    Department of Cardiovascular Prevention & Research Unit Clinic & Laboratory of Pathophysiology, National and Kapodistrian Univ. of Athens, Greece.
  • Petros P Sfikakis
    1st Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Vijay Viswanathan
    MV Hospital for Diabetes and Professor M Viswanathan Diabetes Research Centre, Chennai, India.
  • George D Kitas
    Arthritis Research UK Centre for Epidemiology, Manchester University, Manchester, UK.
  • Andrew Nicolaides
    Vascular Screening and Diagnostic Centre, London, England, United Kingdom; Vascular Diagnostic Center, University of Cyprus, Nicosia, Cyprus.
  • Ajay Gupta
  • Jasjit S Suri
    Advanced Knowledge Engineering Center, Global Biomedical Technologies, Inc., Roseville, CA, USA. Electronic address: jsuri@comcast.net.